A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent

Status Active, not recruiting

Clinical Trial Summary

The Purpose of this study is to investigate changes in alcohol consumption in the period leading up to the onset of pancreatitis and compare that to levels of drinking during asymptomatic periods.

Clinical Trial Description

There is no question that long-term heavy consumption of alcohol leads to increased risk of recurrent acute and chronic pancreatitis. While many patients and providers assume that heavy episodic alcohol consumption leads to acute pancreatitis, it is yet unknown whether 'binge' drinking truly causes pancreatitis and if so, what the relevant timing and duration of hazardous alcohol consumption is. Because of the lack of clarity on the transient effects of alcohol on acute pancreatitis, patients and providers are left with an uncertain disease progression and lack of tailored alcohol reduction recommendations. Our study aims to investigate changes in alcohol consumption in the period leading up to the onset of pancreatitis and compare that to levels of drinking during asymptomatic periods. This epidemiologic design is called the case-crossover study, in which the diseased person serves as his/her own control. This study design has advantages over typical case-control studies in that factors that do not change within the individual, such as sex, race, genetic risks, will not interfere with evaluating the causal role of heavy episodic drinking on pancreatitis. Participants in this study will undergo detailed interview on recent and lifetime alcohol consumption and other correlated health behaviors while they are hospitalized. Blood and urine will be collected during the hospitalization. After discharge, they will be interviewed again for any changes in alcohol consumption and blood and urine will be collected during a standard of care visit. The investigators will chart the progression of their disease through quarterly check-up by phone and through the medical records. Ultimately, the investigators aim to generate data that will empower patients and providers to develop tailored regimens for prevention of recurrent acute pancreatitis, that will have lasting beneficial effects in averting irreversible damage to the pancreas. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04743323
Study type	Observational
Source	Cedars-Sinai Medical Center
Contact
Status	Active, not recruiting
Phase
Start date	June 1, 2020
Completion date	June 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05009251` - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake	N/A
Recruiting	`NCT04356924` - Psychological Treatment to Support the Consequences of Cognitive Impairment	N/A
Completed	`NCT05509049` - Precision Nudging Drives Wellness Visit Attendance at Scale	N/A
Completed	`NCT03904992` - Intervention With a Progressive Web App for the Promotion of Healthy Habits in Preschoolers	N/A
Completed	`NCT05509270` - Efficacy of Communication Modalities for Promoting Flu Shots	N/A
Completed	`NCT03167372` - Pilot Comparison of N-of-1 Trials of Light Therapy	N/A
Completed	`NCT03081520` - Affective Responses Following Aerobic Exercise With Different Intensities	N/A
Completed	`NCT05012163` - Lottery Incentive Nudges to Increase Influenza Vaccinations	N/A
Completed	`NCT03982095` - Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer
Recruiting	`NCT06467058` - Convergent Validity of DABQ Questionnaire	N/A
Completed	`NCT02777086` - Sustainable HIV Risk Reduction Strategies for Probationers	N/A
Completed	`NCT02996864` - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II	N/A
Not yet recruiting	`NCT06071130` - Emotion, Aging, and Decision Making	N/A
Active, not recruiting	`NCT04152824` - Readiness Supportive Leadership Training	N/A
Active, not recruiting	`NCT05541653` - The IGNITE Study on Concentrated Investment in Black Neighborhoods	N/A
Completed	`NCT03875768` - Nourish: A Digital Health Program to Promote the DASH Eating Plan Among Adults With High Blood Pressure	N/A
Completed	`NCT04089020` - Walking to School Supports	N/A
Completed	`NCT03646903` - Reducing Help-Seeking Stigma in Young Adults at Elevated Suicide Risk	N/A
Completed	`NCT03548077` - POWERPLAY: Promoting Men's Health at Work	N/A
Recruiting	`NCT05249465` - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis — ACCESS-AP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms